Macular Degeneration Treatment Market Report 2023 | Global Industry Growth and Forecast 2028

IMARC Group has recently released a new research study titled "Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", the global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/macular-degeneration-treatment-market/requestsample

Macular degeneration is a medical condition that affects the eyes and causes blurriness and loss of vision in the center of the visual field. The treatment of macular degradation depends on the type and severity of the condition, including dry age-related and wet age-related macular degeneration. It helps to slow the progression of macular degeneration, preserve vision, and prevent further loss of vision. At present, macular degeneration treatment is gaining traction as it helps individuals to maintain their independence and perform daily activities.

Macular Degeneration Treatment Market Trends and Drivers:

The growing geriatric population and the increasing number of people affected by macular degeneration represent one of the key factors positively influencing the market. In addition, sedentary lifestyles and changing dietary patterns are resulting in the development of macular degeneration.

Apart from this, the increasing utilization of smartphones, laptops, and televisions, is also contributing to the occurrence of the disorder, which, in turn, is catalyzing the demand for macular degeneration treatment. Moreover, increasing patient awareness and education about macular degeneration and the growing knowledge about the importance of regular eye check-ups are strengthening the market growth.

Furthermore, advancements in diagnostic technologies, such as molecular imaging, that enable early detection of macular degeneration are stimulating the growth of the market worldwide.

Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5118&flag=F

Global Macular Degeneration Treatment Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

The report has segmented the market on the basis of region, type, stage of disease, route of administration and end user.

Breakup by Type:
• Dry Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Breakup by Stage of Disease:
• Early Stage
• Intermediate Stage
• Late Stage

Breakup by Route of Administration:
• Intravenous Route
• Intravitreal Route

Breakup by End User:
• Hospitals
• Ambulatory Surgical Center
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea,
Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/macular-degeneration-treatment-market

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Research Reports:

Continuous Glucose Monitoring Systems Market : https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market

Blood Plasma Derivatives Market : https://www.imarcgroup.com/blood-plasma-derivatives-market

Mucosal Atomization Devices Market : https://www.imarcgroup.com/mucosal-atomization-devices-market

Medical Document Management Systems Market : https://www.imarcgroup.com/medical-document-management-systems-market

Neonatal Ventilator Market : https://www.imarcgroup.com/neonatal-ventilator-market

Cancer Cachexia Market : https://www.imarcgroup.com/cancer-cachexia-market

Pediatric Interventional Cardiology Market : https://www.imarcgroup.com/pediatric-interventional-cardiology-market

Radiology Information System Market : https://www.imarcgroup.com/radiology-information-system-market

Pharmacovigilance and Drug Safety Software Market : https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.